Sarepta Therapeutics | SRPT - 税前利润



金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 571.15M
销售成本
USD 150.1M
流动资产
USD 2.22B
流动负债
USD 502.91M
债务
USD 1.04B
EBIT
USD 13.29M
EBITDA
USD 375.48M
员工
1.37K
EPS每股收益
USD 0.64
股本和储备
USD 1.53B
销售毛利
USD 251.15M
债务利息支出
USD 21.51M
利息收入
USD 7M
贷款资金
USD 847.62M
市值
USD 1.71B
净收入
USD 330.96M
营业费用
USD 387.96M
营业利润
USD 13.29M
普通股股本
USD 105.62M
PE价格收益
27.27
税前利润
USD -1.75M
销售收入
USD 401.3M
销售和管理费用
USD 107.6M
股票
USD 904.27M
贸易债权人
USD 50.98M
应收帐款人
USD 393.8M


税前利润 更改 日
Acadia Pharmaceuticals USD 46.47M 42.49M 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Alnylam Pharmaceuticals USD 177.81M 43.85M 2026-06
Amgen USD 2.08B 570M 2026-03
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Daiichi Sankyo JPY -6.52B 113.25B 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
Incyte USD 751.51M 407.91M 2026-06
Insmed USD -11.37M 150.72M 2026-06
Ionis Pharmaceuticals USD -114M 21M 2026-06
Moderna USD -1.33B 535M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Novavax USD 17.9M 220.94M 2025-12
Pfizer USD -653M 5.84B 2026-06
PTC Therapeutics USD -2.46M 136.62M 2026-03
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR 837M 1.17B 2026-06
Sarepta Therapeutics USD -1.75M 344.92M 2026-06
Tectonic Therapeutic USD -18.97M 63K 2025-12
Ultragenyx Pharmaceutical USD -91M 93M 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06